Research Article

Prognostic Value of the Red Cell Distribution Width in Patients with Sepsis-Induced Acute Respiratory Distress Syndrome: A Retrospective Cohort Study

Table 1

Baseline data of the study subjects.

VariableTotal () () () value

Age, year0.098
Male, (%)660 (56.8%)340 (60.7)320 (53.3)0.010
Ethnicity, (%)0.749
 White811 (69.9)394 (70.4)417 (69.4)
 Black85 (7.3)43 (7.7)42 (7.0)
 Other265 (22.8)123 (22.0)142 (23.6)
SOFA, median (IQR)7 (4–10)6 (4–9)5 (7–11)<0.001
ARDS stage, (%)0.018
 Mild326 (28.1)148 (26.4)178 (29.6)
 Moderate517 (44.5)273 (48.8)244 (40.6)
 Severe318 (27.4)139 (24.8)179 (29.8)
Vasopressin use, (%)609 (52.5)269 (48.0)340 (56.6)0.004
Comorbidities, (%)
 Congestive heart failure242 (20.8)98 (17.5)144 (24.0)0.007
 Chronic pulmonary291 (25.1)126 (22.5)165 (27.5)0.052
 Hypertension174 (15.0)55 (9.8)119 (19.8)<0.001
 Renal failure198 (17.1)61 (10.9)137 (22.8)<0.001
 Liver disease118 (10.2)28 (5.0)90 (15.0)<0.001
 Anemia299 (25.8)121 (21.6)178 (29.6)0.002
Laboratory data
 White blood cell, 109/L10.6 (7.6–14.3)10.9 (8.2–14.3)10 (6.9–14.3)0.006
 Platelet, 109/L202 (147–271)212 (167–278)186 (125–264)<0.001
 Glucose, mg/dL133 (107–175)136 (110–178)129 (104–173)0.003
 Creatinine, mg/dL1.1 (0.8–1.7)1.0 (0.8–1.5)1.2 (0.8–2.1)<0.001
 Urea nitrogen, mg/dL22 (15–37)19.5 (13.0–29.0)26 (17–44)<0.001
Clinical outcome
 30-day mortality, (%)318 (27.4)104 (18.6)214 (35.6)<0.001
 90-day mortality, (%)379 (32.6)122 (21.8)257 (42.8)<0.001